Custom Search

News

Saturday 01 November 2003

Successful treatment of refractory myasthenia gravis using rituximab: a pediatric case report.

By: Wylam ME, Anderson PM, Kuntz NL, Rodriguez V.

J Pediatr 2003 Nov;143(5):674-7

We report the successful use of anti-CD20 therapy in a child with refractory myasthenia gravis (MG), an antibody-mediated autoimmune disease, who did not respond to conventional therapy. After initiation of anti-CD20 therapy, clinical improvement (muscular strength, pulmonary function) was observed.

Use of this site is subject to the following terms of use